RAET1L and neoplasm: Blocking the immunosuppressive effects of sULBP6 also resulted in enhanced PBMC-mediated tumor cell killing (Fig. 4E; Supplementary Table S9), suggesting that Fc-Att-anti-ULBP6/2/5 can restore PBMC-mediated tumor growth control.